Tag: Psychiatric drugs


RISPERIDONE

Pharmacological Classification and Mechanism of Action Risperidone is a potent second-generation antipsychotic (SGA), commonly referred to as an atypical antipsychotic, belonging to the benzisoxazole derivative class. Unlike first-generation antipsychotics which primarily target dopamine D2 receptors, risperidone is characterized by its high affinity for both serotonin 5-HT2A and dopamine D2 receptors. This dual-antagonism is central to […]

Read More

Drugs that Increase Dopamine for Depression

Introduction to Dopamine and Depression Depression, clinically known as Major Depressive Disorder (MDD), represents a debilitating and highly prevalent mental health condition globally. Characterized by persistent feelings of sadness, anhedonia (the inability to experience pleasure), significant changes in appetite and sleep patterns, and profound difficulties in cognitive functioning, depression significantly impairs quality of life. Traditional […]

Read More

DOXEPIN

Introduction and Chemical Classification Doxepin is chemically classified as a tricyclic antidepressant (TCA), derived from the dibenzoxepin ring structure. Developed in the mid-20th century, it quickly became a cornerstone medication in psychopharmacology for the treatment of major depressive disorder and various anxiety states. Unlike newer agents which are often highly selective, Doxepin is characterized by […]

Read More

ETRAFON

ETRAFON: A Combination Therapy Etrafon is a historical and clinically significant trade name representing a fixed-dose combination medication utilized in the field of psychopharmacology. It is fundamentally defined by the co-formulation of two distinct classes of psychotropic agents: a tricyclic antidepressant (TCA) and a first-generation antipsychotic (FGA). This specific therapeutic pairing was developed to address […]

Read More

STELAZINE

Introduction to Stelazine (Trifluoperazine) Stelazine is the long-established trade name for the pharmaceutical compound trifluoperazine, a highly potent agent classified within the typical, or first-generation, antipsychotic category. As a member of the piperazine subclass of phenothiazines, trifluoperazine has historically played a crucial role in the management of severe psychiatric disorders, primarily schizophrenia and certain acute […]

Read More

PERPHENAZINE

Introduction and Pharmacological Classification Perphenazine is classified as a conventional, or first-generation, antipsychotic drug, falling specifically within the chemical subgroup of the piperazine phenothiazines. Introduced clinically in the mid-20th century, it quickly established itself as a potent agent in the management of severe psychiatric disturbances. Its chemical structure, characterized by a piperazine side chain attached […]

Read More

ALIPHATIC PHENOTHIAZINES

Introduction to Aliphatic Phenothiazines The class of compounds known as aliphatic phenothiazines represents a foundational group within the broader spectrum of antipsychotic medications, characterized fundamentally by the presence of an aliphatic side chain attached to the nitrogen atom at position 10 of the phenothiazine nucleus. This specific structural characteristic distinguishes them chemically and pharmacologically from […]

Read More

TARACTAN

Chlorprothixene (Taractan) The Core Definition and Pharmacological Class Chlorprothixene is a pharmaceutical agent classified as a typical, or first-generation, antipsychotic medication. It is most widely recognized in clinical settings by its primary trade name, Taractan. While the drug itself is chemically defined by its structure—it belongs to the thioxanthene class of compounds—its function is rooted […]

Read More

THORAZINE

Thorazine (Chlorpromazine) Introduction to Thorazine (Chlorpromazine) Core Definition: Thorazine, known generically as chlorpromazine, is a seminal antipsychotic medication belonging to the phenothiazine class. It represents a monumental breakthrough in modern psychopharmacology, revolutionizing the treatment of severe mental illnesses. Introduced in the 1950s, its advent marked the beginning of effective pharmacological interventions for conditions characterized by […]

Read More